[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339156-105":59,"doc-detail-339156-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cinobufotalin-regulates-the-usp36c-myc-axis-to-suppress-malignant-phenotypes-of-colon-cancer-cells-in-vitro-and-in-vivo","Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo","","Ubiquitin-specific protease 36 (USP36) is reported to drive oncogenic effects in multiple cancers, yet its role in colon cancer progression has remained unclear. This study integrates bioinformatics and experimental assays to test whether USP36 governs malignant behaviors of colon cancer cells and to evaluate USP36 as a drug target. USP36 is elevated in colon cancer and further increased in oxaliplatin-resistant cells, promoting proliferation, migration, invasion, resistance, and stemness via c-Myc stabilization. Cinobufotalin inhibits USP36 deubiquitination, reverses oxaliplatin resistance, and suppresses malignant phenotypes in vitro and in vivo.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cinobufotalin-regulates-the-usp36c-myc-axis-to-suppress-malignant-phenotypes-of-colon-cancer-cells-in-vitro-and-in-vivo/339156/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cinobufotalin-regulates-the-usp36c-myc-axis-to-suppress-malignant-phenotypes-of-colon-cancer-cells-in-vitro-and-in-vivo/339156.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does USP36 play in colon cancer cells?","Question",{"text":113,"@type":114},"USP36 is highly expressed in colon cancer and becomes further up-regulated in oxaliplatin-resistant cells, where it promotes proliferation, migration, invasion, and stemness.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does USP36 influence c-Myc in colon cancer cells?",{"text":118,"@type":114},"USP36 enhances c-Myc protein stabilization through deubiquitination, reducing c-Myc degradation and supporting malignant phenotypes.",{"name":120,"@type":111,"acceptedAnswer":121},"What is cinobufotalin’s effect in relation to USP36 and oxaliplatin resistance?",{"text":122,"@type":114},"Cinobufotalin is identified as a potential USP36 inhibitor that blocks deubiquitination activity, suppressing malignant behaviors and reversing oxaliplatin resistance in HCT116 cells.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339156,1790104066,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 6  \nResearch Paper  \nCinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo  \nYongjun Hu1, Ming Luo1  \n1 Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China  \nCorrespondence to: Ming Luo; email: [luoming@csu.edu.cn](luoming@csu.edu.cn)  \n[Keywords:](Keywords: colon cancer)[ colon cancer](Keywords: colon cancer), USP36, oxaliplatin, c-Myc, cinobufotalin  \nReceived: July 18, 2023 Accepted: January 4, 2024 Published: March 15, 2024  \nCopyright: © 2024 Hu and Luo. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nUbiquitin-specific protease 36 (USP36) has been reported to exhibit oncogenic effects in various malignancies, but the function of USP36 in colon cancer progression remains indefinite. Herein, we aimed to determine the role and mechanism of USP36 in malignant phenotypes of colon cancer cells and explore the potential drug targeting USP36 . Bioinformatics analyses indicated that USP36 is highly expressed and significantly related to tumor stages in colon cancer. Besides, USP36 was further up-regulated in oxaliplatin (Oxa)-resistant colon cancer cells. Colony formation, Edu staining, Transwell, wound healing, sphere formation, and CCK-8 assays were conducted and showed that the proliferation, Oxa-resistance, migration, stemness, and invasion of HCT116 cells were promoted after overexpressing USP36, while suppressed by USP36 knockdown. Mechanically, USP36 enhances c-Myc protein stabilization in HCT116 cells via deubiquitination. AutoDock tooland ubiquitin-AMC hydrolysis assay identified cinobufotalin (CBF), an anti-tumor drug, maybe a USP36 inhibitor by inhibiting its deubiquitination activity. CBF significantly prohibited proliferation, migration, invasion, and stemness of HCT116 cells and reversed Oxa-resistance, whereas enforced expression of USP36 blocked these effects. Moreover, in vivo analyses confirmed the oncogenic role of USP36 and the therapeutic potential of CBFin the malignancy of colon cancer. In conclusion, CBF may be a promising therapeutic agent for colon cancer due to its regulation of the USP36/c-Myc axis.  \nINTRODUCTION  \nColon cancer is the fifth most common malignancy with an estimated 1.15 million new cases worldwide in 2020 [1] . Despite the advances in detection and treatment over the past decade, colon cancer is the third leading cause of cancer death in the world, representing 5.5% of mortality, which remains a vital public health issue [1] . Among all diagnosed colon cancer, more than half of them have spread to surrounding tissues or distant parts of the body, which exhibit a higher rate of metastasis and recurrence [2], thereby leading to a poor prognosis [3] . Endoscopicor surgical resection is not an optimal choice for late-stage colon cancer [4] . Meanwhile, multidrug resistance has become the most challenging obstacle impeding the success of both radiotherapy and  \nchemotherapy [5] . Therefore, uncovering novel molecular mechanisms related to carcinogenesis as well as the progression of colon cancer can aid the development of novel effective therapeutic targets for this malignancy, which is critical to improving the survival rates of patients with colon cancer.  \nIn the last two decades, the critical role of post-translational modifications (PTMs), such as phosphorylation, methylation, as well as acetylation, in the pathogenesis of cancer has grabbed the attention from researchers around the world [6] . As two mutually reversible PTMs, ubiquitylation and deubiquitylation play many critical regulatory roles in multiple cell physiological and pathological processes, which include protein stabilization, me","cbCaiismezjH2pMF","https://ap.wps.com/l/cbCaiismezjH2pMF","pdf",3717174,"English","# Abstract\n# Introduction\n# Results\n## USP36 expression in colon cancer and oxaliplatin-resistant cells","[{\"question\":\"What role does USP36 play in colon cancer cells?\",\"answer\":\"USP36 is highly expressed in colon cancer and becomes further up-regulated in oxaliplatin-resistant cells, where it promotes proliferation, migration, invasion, and stemness.\"},{\"question\":\"How does USP36 influence c-Myc in colon cancer cells?\",\"answer\":\"USP36 enhances c-Myc protein stabilization through deubiquitination, reducing c-Myc degradation and supporting malignant phenotypes.\"},{\"question\":\"What is cinobufotalin’s effect in relation to USP36 and oxaliplatin resistance?\",\"answer\":\"Cinobufotalin is identified as a potential USP36 inhibitor that blocks deubiquitination activity, suppressing malignant behaviors and reversing oxaliplatin resistance in HCT116 cells.\"}]","Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo | PDF",1790028290,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9440218336d5fed29b2e40e7c1c3aa8d.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07a38f641149c830656bb596e8d2b187.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5fa7d55606a130676f60773576c65197.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e835f0f9b091dc7a842e94cbb4c66986.webp",980,1268]